NantKwest(NK)

32.49 0.00 0.0%

今开:0.0昨收:32.49
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.552605177E9

NantKwest的最新讨论

合作开发通用实体瘤NK样细胞疗法,新锐B轮融资超5亿

医麦客2023-02-19 07:37

2023年2月19日/医麦客新闻 eMedClub News/--近日,临床阶段公司GAIA BioMedicine宣布和TreeFrog Therapeutics合作,利用TreeFrog 的C-Stem™技术大规模扩增针对实体瘤的同种异体NK样细胞,进而解决NK样细胞的供应难题。早在2021年,TreeFrog Therapeutics完成了7500万美元的B轮融资以推进C-Stem:...查看全文

资本主义拉美行不通2022-05-11 09:16

回复@进雪球做方丈: 制造业占比高的国家,你可以拉个清单看看都是些什么国家。Industry (including construction), value added (% of GDP) | Data (worldbank.org){Industry (including construction), value added (% of GDP) | Data (worldbank.org)}
网页链接查看全文

1 2 3 4 5 6 7 8

NantKwest的公告

$NantKwest(NK)$ 内部交易: 2019-09-09,Director,Thomas John C ,卖出,13956普通股, $1.24

$NantKwest(NK)$ 内部交易: 2019-09-06,Director,Thomas John C ,卖出,7080普通股, $1.24

$NantKwest(NK)$ 内部交易: 2019-09-05,Director,Thomas John C ,卖出,2964普通股, $1.25

$NantKwest(NK)$ EFFECT - Notice of Effectiveness Filed: 2019-09-03 AccNo: 9999999995-19-002013 Size: 1 KB 网页链接

$NantKwest(NK)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-08-23 AccNo: 0001193125-19-227893 Size: 644 KB 网页链接

$NantKwest(NK)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-07 AccNo: 0001193125-19-215293 Size: 55 KB 网页链接

$NantKwest(NK)$ 8-K - Current report Filed: 2019-08-07 AccNo: 0001193125-19-215311 Size: 184 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$NantKwest(NK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-06 AccNo: 0001564590-19-029330 Size: 10 MB 网页链接

$NantKwest(NK)$ 内部交易: 2019-08-02,CFO,Nelson Sonja ,期权,10000普通股, $0.00

$NantKwest(NK)$ 8-K - Current report Filed: 2019-06-10 AccNo: 0001193125-19-169172 Size: 349 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22